НовостиBenzingaTruist Securities Maintains Buy on BeOne Medicines, Raises Price Target to $420 Truist Securities Maintains Buy on BeOne Medicines, Raises Price Target to $420 Benzinga 2026.10.07 15:38 (GMT+0) Открыть на Benzinga Другие новости